Richard Gesser
Sanofi (United States)(US)
Publications by Year
Research Areas
Herpesvirus Infections and Treatments, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus, Cytomegalovirus and herpesvirus research, Bacterial Identification and Susceptibility Testing
Most-Cited Works
- → A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women(2015)1,394 cited
- → Ertapenem Once Daily Versus Piperacillin‐Tazobactam 4 Times per Day for Treatment of Complicated Skin and Skin‐Structure Infections in Adults: Results of a Prospective, Randomized, Double‐Blind Multicenter Study(2002)130 cited
- → Treatment of Experimental Intracranial Murine Melanoma with a Neuroattenuated Herpes Simplex Virus 1 Mutant(1995)109 cited
- → Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial(2016)97 cited
- → Presence of VZV and HSV-1 DNA in Human Nodose and Celiac Ganglia(2001)89 cited
- → Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial(2020)73 cited
- → Multiplexed Serologic Assay for Nine Anogenital Human Papillomavirus Types(2010)69 cited
- → Ertapenem versus Ceftriaxone Followed by Appropriate Oral Therapy for Treatment of Complicated Urinary Tract Infections in Adults: Results of a Prospective, Randomized, Double-Blind Multicenter Study(2002)67 cited
- → Chronic fatigue in children(1991)66 cited
- → A review of the molecular mechanism of HSV-1 latency(1991)58 cited